Pages that link to "Q41404494"
Jump to navigation
Jump to search
The following pages link to Clinicopathological impact of the interaction between megakaryocytes and myeloid stroma in chronic myeloproliferative disorders: a concise update (Q41404494):
Displaying 13 items.
- In vitro antiproliferative activity of the farnesyltransferase inhibitor R115777 in hematopoietic progenitors from patients with myelofibrosis with myeloid metaplasia (Q33348021) (← links)
- Myelofibrosis with myeloid metaplasia (Q33357164) (← links)
- Pathogenesis and management of idiopathic myelofibrosis (Q33820411) (← links)
- Comparative effects of interferon and hydroxyurea on bone marrow fibrosis in chronic myelogenous leukemia (Q34430341) (← links)
- Choosing between stem cell therapy and drugs in myelofibrosis (Q34734491) (← links)
- Angiogenesis and anti-angiogenic therapy in myelofibrosis with myeloid metaplasia (Q35994847) (← links)
- Replacement of hematopoietic system by allogeneic stem cell transplantation in myelofibrosis patients induces rapid regression of bone marrow fibrosis (Q36012537) (← links)
- A critical reappraisal of the WHO classification of the chronic myeloproliferative disorders (Q36362041) (← links)
- Selectins (CD62L, CD62P) and megakaryocytic glycoproteins (CD41a, CD42b) mediate megakaryocyte-fibroblast interactions in human bone marrow (Q42495898) (← links)
- SU6668 in idiopathic myelofibrosis--a rational therapeutic approach targeting several tyrosine kinases of importance for the myeloproliferation and the development of bone marrow fibrosis and angiogenesis (Q44530765) (← links)
- Imatinib mesylate in idiopathic and postpolycythemic myelofibrosis (Q44667229) (← links)
- Collagen metabolism and enzymes of the urokinase plasminogen activator system in chronic myeloproliferative disorders: correlation between plasma-soluble urokinase plasminogen activator receptor and serum markers for collagen metabolism. (Q54008969) (← links)
- Analysis of risk factors of the evolution of myelofibrosis in pre-fibrotic chronic idiopathic myelofibrosis: a retrospective study based on follow up biopsies of 70 patients by using the RECPAM method (Q80128477) (← links)